• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Korean Med Sci . Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandem

tetano

Editor, Senior Moderator
J Korean Med Sci


. 2022 Feb 28;37(8):e67.
doi: 10.3346/jkms.2022.37.e67.
Kinetics of Neutralizing Antibody Responses Against SARS-CoV-2 Delta Variant in Patients Infected at the Beginning of the Pandemic


Pyoeng Gyun Choe[SUP] #[/SUP][SUP] 1 [/SUP], Yuri Kim[SUP] #[/SUP][SUP] 2 [/SUP], Euijin Chang[SUP] 1 [/SUP], Chang Kyung Kang[SUP] 1 [/SUP], Nam Joong Kim[SUP] 1 [/SUP], Nam-Hyuk Cho[SUP] 3 [/SUP], Wan Beom Park[SUP] 4 [/SUP], Myoung-Don Oh[SUP] 1 [/SUP]



Affiliations

Abstract

We investigated the kinetics of the neutralizing antibody responses to the severe acute respiratory syndrome-coronavirus-2 delta variant over the course of 1 year in 16 patients infected at the beginning of the pandemic. In patients with severe disease, neutralizing responses to the delta variant were detectable, albeit at lower levels than responses to the wild type. Neutralizing responses to the delta variant were undetectable, however, in asymptomatic persons. This finding implies that the vaccination strategy for persons with past natural infection should depend on the severity of the previous infection.

Keywords: COVID-19; Delta Variant; FRNT; SARS-CoV-2.
 
Back
Top Bottom